We unleash your business potential by maximize the business innovation.
Send EmailLeucine, L-Leucine, 61-90-5
CAS Number: 61-90-5
EC Number (EINECS): 200-522-0
Molecular Formula: C₆H₁₃NO₂
Molecular Weight: 131.17 g/mol
Chemical Class: Essential amino acid (branched-chain amino acid - BCAA)
SECTION 1: CHEMICAL IDENTITY AND DEFINITION
| Parameter | Information |
|---|---|
| Chemical Name (IUPAC) | (S)-2-Amino-4-methylpentanoic acid |
| Other Names | L-Leucine, Leucine, 2-Amino-4-methylpentanoic acid, L-α-Amino-4-methylpentanoic acid, (S)-α-Amino-4-methylpentanoic acid |
| Chemical Formula | C₆H₁₃NO₂ |
| Molecular Weight | 131.17 g/mol |
| CAS Number | 61-90-5 |
| EC Number (EINECS) | 200-522-0 |
| Chemical Class | Essential amino acid (branched-chain amino acid - BCAA) |
| Appearance | White, crystalline powder |
| Odor | Odorless |
| Taste | Slightly bitter |
| Physical State (20°C) | Solid (crystalline powder) |
| Optical Activity | L-form (natural, biologically active) |
| Solubility | Slightly soluble in water (~22 g/L at 25°C); insoluble in ethanol and ether |
SECTION 2: PHYSICAL PROPERTIES
| Property | Value |
|---|---|
| Appearance | White, crystalline powder |
| Odor | Odorless |
| Taste | Slightly bitter |
| Molecular Weight | 131.17 g/mol |
| Melting Point | ~293 °C (decomposes) |
| Density | ~1.23 g/cm³ |
| Solubility in Water (25°C) | Slightly soluble (~22 g/L) |
| Solubility in Ethanol | Insoluble |
| Solubility in Ether | Insoluble |
| pH (1% solution) | 5.5 – 6.5 |
| Specific Rotation [α]D²⁰ | +14.5° to +16.5° |
| pKa₁ (COOH) | 2.36 |
| pKa₂ (NH₃⁺) | 9.60 |
| Isoelectric Point | 5.98 |
SECTION 3: CHEMICAL PROPERTIES
| Property | Information |
|---|---|
| Chemical Formula | C₆H₁₃NO₂ |
| Molecular Weight | 131.17 g/mol |
| Chemical Class | Essential amino acid (branched-chain amino acid - BCAA) |
| Functional Groups | Amino (-NH₂), carboxyl (-COOH) |
| Structure | α-amino acid with branched isobutyl side chain |
| SMILES | CC(C)CC(C(=O)O)N |
| InChI Key | ROHFNLRQFUQHCH-YFKPBYRVSA-N |
| Optical Activity | L-form (natural, biologically active) |
| Stability | Stable under normal storage conditions |
| Hygroscopicity | Low |
| Incompatible Materials | Strong oxidizing agents, strong acids, strong bases |
Chemical Structure:
NH₂
|
CH₃-CH-CH₂-CH-COOH
|
CH₃
(L-Leucine / (S)-2-Amino-4-methylpentanoic acid)
SECTION 4: BIOLOGICAL SIGNIFICANCE
| Parameter | Description |
|---|---|
| Essential Amino Acid | Cannot be synthesized by the human body; must be obtained from diet |
| BCAA Member | One of three branched-chain amino acids (leucine, isoleucine, valine) |
| Muscle Protein Synthesis | Primary activator of the mTOR pathway; initiates muscle protein synthesis |
| Muscle Growth | Most anabolic of all amino acids; critical for muscle hypertrophy |
| Recovery | Supports post-exercise muscle recovery and repair |
| Regulatory Role | Regulates protein metabolism; inhibits protein breakdown |
| Glucose Metabolism | May improve insulin sensitivity and glucose metabolism |
| Metabolism | Metabolized primarily in muscle tissue (not liver) |
SECTION 5: BCAA COMPARISON
| Property | L-Leucine | L-Isoleucine | L-Valine |
|---|---|---|---|
| Chemical Formula | C₆H₁₃NO₂ | C₆H₁₃NO₂ | C₅H₁₁NO₂ |
| Molecular Weight | 131.17 g/mol | 131.17 g/mol | 117.15 g/mol |
| Side Chain | Isobutyl | Sec-butyl | Isopropyl |
| Anabolic Effect | Strongest | Moderate | Moderate |
| mTOR Activation | Primary activator | Weak | Weak |
| Muscle Growth | Most critical | Important | Important |
| Energy Production | Moderate | Highest | Moderate |
| Common BCAA Ratio | 2:1:1 | 1 | 1 |
SECTION 6: APPLICATION AREAS
6.1. Sports Nutrition (Highest Suitability)
| Application | Function |
|---|---|
| BCAA Formulations | Most critical component; typically used in 2:1:1 ratio |
| Muscle Protein Synthesis | Activates mTOR pathway; initiates muscle growth |
| Muscle Recovery | Accelerates post-workout recovery |
| Pre-Workout Supplements | Prevents muscle breakdown during exercise |
| Post-Workout Supplements | Stimulates muscle protein synthesis |
| Protein Powders | Enriched with leucine for enhanced anabolic effect |
| Intra-Workout Drinks | Maintains performance; reduces fatigue |
6.2. Dietary Supplements
| Application | Function |
|---|---|
| Amino Acid Blends | Component in complete amino acid formulations |
| Protein Powders | Leucine-fortified protein supplements |
| Weight Management | Supports lean muscle mass preservation |
| General Health | Supports muscle maintenance |
6.3. Medical Applications (Research Stage)
| Application | Function |
|---|---|
| Sarcopenia | Age-related muscle loss prevention |
| Cachexia | Cancer-related muscle wasting treatment |
| Liver Disease | Hepatic encephalopathy research |
| Glucose Metabolism | Insulin sensitivity studies |
| Metabolic Research | Amino acid metabolism studies |
6.4. Food Industry
| Application | Function |
|---|---|
| Functional Foods | Fortified foods and beverages |
| Sports Drinks | Performance-enhancing beverages |
| Protein Bars | High-protein snack formulations |
6.5. Research & Biochemistry
| Application | Function |
|---|---|
| Amino Acid Metabolism | Metabolic pathway studies |
| Protein Synthesis | Mechanism of protein synthesis research |
| Enzyme Studies | Enzyme-substrate interaction research |
SECTION 7: TYPICAL DOSAGE
| Application | Recommended Daily Dose |
|---|---|
| Muscle Building (Athletes) | 2-5 g/day (as part of BCAA 2:1:1) |
| General BCAA Supplementation | 3-6 g/day |
| Post-Workout | 2-3 g |
| Pre-Workout | 2-3 g |
| Therapeutic Use | 1-3 g/day (under supervision) |
| Typical BCAA Ratio | 2:1:1 (Leucine:Isoleucine:Valine) |
SECTION 8: QUALITY SPECIFICATIONS (FOOD GRADE)
| Parameter | Specification (USP / Ph. Eur. / FCC) |
|---|---|
| Appearance | White, crystalline powder |
| Identification | Positive (IR, HPLC) |
| Assay (on dried basis) | 98.5 – 101.5% |
| Specific Rotation [α]D²⁰ | +14.5° to +16.5° |
| Loss on Drying | ≤ 0.5% |
| Residue on Ignition | ≤ 0.1% |
| pH (1% solution) | 5.5 – 6.5 |
| Chlorides (Cl) | ≤ 0.02% |
| Sulfates (SO₄) | ≤ 0.02% |
| Heavy Metals (as Pb) | ≤ 10 ppm |
| Lead (Pb) | ≤ 2 ppm |
| Arsenic (As) | ≤ 3 ppm |
| Mercury (Hg) | ≤ 1 ppm |
| Cadmium (Cd) | ≤ 1 ppm |
| Ammonium (NH₄) | ≤ 0.1% |
| Other Amino Acids | ≤ 0.5% |
| Chiral Purity (HPLC) | ≥ 99.0% |
SECTION 9: MICROBIOLOGICAL SPECIFICATIONS
| Parameter | Specification |
|---|---|
| Total Aerobic Mesophilic Bacteria | ≤ 1,000 CFU/g |
| Yeast and Mold | ≤ 100 CFU/g |
| Salmonella spp. | Negative in 25g |
| Escherichia coli | Negative in 10g |
| Staphylococcus aureus | Negative in 1g |
| Pseudomonas aeruginosa | Negative in 1g |
SECTION 10: STORAGE AND SHELF LIFE
| Parameter | Information |
|---|---|
| Storage Conditions | Cool (15-25°C), dry, well-ventilated area |
| Container Requirements | Tightly closed, original packaging |
| Protect From | Moisture, strong oxidizing agents, strong acids, strong bases |
| Shelf Life | 24-48 months (unopened original packaging) |
SECTION 11: PACKAGING OPTIONS
| Packaging Type | Quantity | Material |
|---|---|---|
| Aluminum foil bag | 1-5 kg | Laminated aluminum |
| PE-lined kraft paper bag | 25 kg | Kraft paper + PE |
| Plastic pail | 20-25 kg | HDPE |
| Fiber drum | 25-50 kg | HDPE + PE |
| Big-Bag | 500-1000 kg | Polypropylene (with PE liner) |
SECTION 12: SAFETY AND HEALTH INFORMATION
GHS Classification (Bulk Powder)
| Hazard Class | Category |
|---|---|
| Not classified as hazardous | - |
Hazard Statements
| Code | Statement |
|---|---|
| None | Not classified as hazardous |
Precautionary Statements
| Code | Statement |
|---|---|
| P261 | Avoid breathing dust |
| P280 | Wear protective gloves/eye protection |
| P305+P351+P338 | IF IN EYES: Rinse cautiously with water for several minutes; remove contact lenses if present and easy to do; continue rinsing |
SECTION 13: TOXICOLOGICAL INFORMATION
| Parameter | Value |
|---|---|
| Oral LD50 (Rat) | > 5,000 mg/kg |
| Skin Irritation | Non-irritant |
| Eye Irritation | Mild irritant |
| Skin Sensitization | Non-sensitizer |
| Carcinogenicity | Not classified |
| Mutagenicity | Negative in standard tests |
| Reproductive Toxicity | No evidence of adverse effects |
| GRAS Status | Generally recognized as safe (GRAS) |
SECTION 14: FIRST AID MEASURES
| Exposure Route | Action |
|---|---|
| Inhalation | Move to fresh air. If respiratory irritation persists, seek medical attention. |
| Skin Contact | Wash with plenty of soap and water. |
| Eye Contact | Rinse immediately with plenty of water for at least 15 minutes. Seek medical attention. |
| Ingestion | Rinse mouth. Drink plenty of water. Seek medical attention. |
SECTION 15: REGULATORY STATUS
| Region / Authority | Status |
|---|---|
| European Union | Approved as food supplement ingredient |
| USA (FDA) | GRAS (Generally Recognized as Safe) |
| Turkey | Approved as food supplement ingredient |
| EFSA | Approved; nutritional substance |
| JECFA | Approved |
SECTION 16: TRANSPORT INFORMATION
| Parameter | Information |
|---|---|
| UN Number | Not regulated (not dangerous goods) |
| Hazard Class | Not applicable |
| Packing Group | Not applicable |
| ADR/RID | Not regulated |
| IMDG Code | Not regulated |
| IATA (Air) | Not regulated |
| Marine Pollutant | No |
SECTION 17: FIRE-FIGHTING MEASURES
| Parameter | Information |
|---|---|
| Fire Hazard | Combustible organic solid |
| Suitable Extinguishing Media | Water spray (mist), CO₂, dry chemical powder |
| Specific Hazards | When heated, emits CO, CO₂, nitrogen oxides |
| Decomposition Products | CO, CO₂, NOx |
| Protective Equipment | Self-contained breathing apparatus (SCBA), full protective clothing |
SECTION 18: ACCIDENTAL SPILLAGE AND CLEANUP
| Parameter | Information |
|---|---|
| Personal Protection | Nitrile gloves, protective goggles, dust mask (N95) |
| Cleaning Methods | Collect mechanically (sweep or spatula) |
| Environmental Precautions | Prevent entry into drains, soil, and surface waters |
| Waste Disposal | According to local regulations; landfilling at licensed facilities |
SECTION 19: OTHER NAMES AND SYNONYMS
| Type | Name |
|---|---|
| Turkish Names | L-Lösin, Lösin, Dallı Zincirli Aminoasit |
| English Names | L-Leucine, Leucine, Branched-Chain Amino Acid (BCAA) |
| Chemical Names | (S)-2-Amino-4-methylpentanoic acid, L-α-Amino-4-methylpentanoic acid |
| Abbreviation | Leu, L |
| CAS Number | 61-90-5 |
| EC Number | 200-522-0 |
SECTION 20: SUMMARY AND CRITICAL NOTES
Product Summary
| Parameter | Value |
|---|---|
| Product | L-Leucine |
| CAS Number | 61-90-5 |
| Appearance | White, crystalline powder |
| Molecular Weight | 131.17 g/mol |
| Primary Function | Muscle protein synthesis activator |
| GRAS | Yes |
| BCAA Ratio | 2:1:1 (Leucine:Isoleucine:Valine) |
Critical Notes
Most Anabolic Amino Acid: Leucine is the most potent amino acid for stimulating muscle protein synthesis.
mTOR Activator: Primary activator of the mTOR pathway, which initiates muscle protein synthesis.
Essential Amino Acid: Cannot be synthesized by the human body; must be obtained through diet or supplementation.
BCAA Member: One of three branched-chain amino acids (leucine, isoleucine, valine); metabolized in muscle tissue (not liver).
Key for Athletes: Critical for muscle growth, recovery, and performance in sports nutrition.
Typical Ratio: Commonly used in 2:1:1 ratio (leucine:isoleucine:valine) in BCAA supplements.
Taste: Slightly bitter taste; often masked in flavored formulations.
Slightly Soluble: Limited solubility in water (~22 g/L at 25°C); insoluble in ethanol and ether.
Safety: Generally recognized as safe (GRAS); well-tolerated at recommended doses.
Regulatory Status: Approved as food supplement ingredient in EU, USA, and Turkey.
IMPORTANT DECLARATION: This Technical Data Sheet (TDS) is for informational purposes only and has been prepared based on available technical data. The user is responsible for determining the product's suitability for their specific application and for complying with all local, national, and international regulations. For complete safety, storage, use, transport, waste, and regulatory compliance information, refer to the official Safety Data Sheet (SDS/MSDS) provided by the manufacturer/supplier. This document does not replace medical advice.